CERES INC COM USD0.01..............

http://www.ariva.de/news/...nd-Quarter-2014-Financial-Results-4994238 GrB  

http://www.ariva.de/news/...-Development-Activities-in-Mexico-5024480 GrB  

07:30 12.05.14

PR Newswire

THOUSAND OAKS, Calif., May 12, 2014

THOUSAND OAKS, Calif., May 12, 2014 /PRNewswire/ -- Ceres, Inc. (Nasdaq: CERE), an agricultural biotechnology and seed company, has been awarded a U.S. patent for a genetic sequence derived from corn, covering uses of the gene in areas such as research, product development and seed production. The company believes that its gene could be useful in regulating plant development and key biosynthetic processes.

Ceres, Inc. logo
Ceres plans to offer other seed companies a commercial license to the innovation, including an opportunity for exclusivity in certain crops. "We are currently evaluating the potential market for this gene among corn seed companies and the applicability of our patented invention in the development and production of improved corn hybrids," said Richard Hamilton, President and CEO of Ceres. He noted that row crops, like corn, provide Ceres an additional outlet for traits and gene technology it has developed for its own use.

The new patent for this invention was issued by the U.S. Patent and Trademark Office as U.S. Patent No. 8,710,201 and is titled, Nucleic Acid Sequences Encoding Strictosidine Synthase Proteins. Ceres owns or maintains exclusive licensed rights to approximately 85 issued patents and approximately 110 pending patent applications in the United States and in various foreign jurisdictions. A patent is an intellectual property right granted by a government to an inventor to exclude others from making, using, offering for sale, or selling the invention for a limited time in exchange for public disclosure of the invention when the patent is granted.

ABOUT CERES

Ceres, Inc. is an agricultural biotechnology company that markets seeds for energy crops used in the production of renewable transportation fuels, electricity and bio-based products. The company combines advanced plant breeding and biotechnology to develop products that can address the limitations of first-generation bioenergy feedstocks, increase biomass productivity, reduce crop inputs and improve cultivation on marginal land. Its development activities include sweet sorghum, high-biomass sorghum, switchgrass and miscanthus. Ceres markets its products under its Blade brand. The company also licenses its technology and biotech traits to other organizations.

CERES FORWARD-LOOKING STATEMENTS

This press release may contain forward-looking statements. All statements, other than statements of historical facts, including statements regarding Ceres' efforts to develop and commercialize its products, anticipated yields and product performance, status of crop plantings, short-term and long-term business strategies, market and industry expectations, future operating metrics, and future results of operations and financial position, including anticipated cost savings from our plan to align expenditures, are forward-looking statements. You should not place undue reliance on these forward-looking statements because they involve known and unknown risks, uncertainties and other factors that are, in some cases, beyond Ceres' control. Factors that could materially affect actual results can be found in Ceres' filings with the U.S. Securities and Exchange Commission. Ceres undertakes no obligation to update publicly, except to the extent required by law, any forward-looking statements for any reason after the date the company issues this press release to conform these statements to actual results or to changes in the company's expectations.

Logo - http://photos.prnewswire.com/prnh/20140509/86224

SOURCE Ceres, Inc.


Quelle: PR Newswire  

Ceres Provides Interim Update on Its Sorghum Hybrids in Brazil
13:35 28.05.14

PR Newswire

THOUSAND OAKS, Calif., May 28, 2014

THOUSAND OAKS, Calif., May 28, 2014 /PRNewswire/ -- Ceres, Inc. (Nasdaq: CERE), an agricultural biotechnology and seed company, today announced that its sorghum hybrids appear to have rebounded from dry conditions in Brazil earlier in the season. Harvests are nearing completion and the company expects to announce final results by July.

Ceres is pursuing two market opportunities in Brazil for its sorghum seed products. The company's high biomass types, which are currently being evaluated in a number of geographies, are intended to be combusted for electricity generation in Brazil's biopower market. Ongoing water shortages and increasing demand for power have led to a spike in electricity prices and increased production of biopower, which the company believes may increase demand for high-biomass sorghum next season. Ceres also continues to work closely with ethanol mills to evaluate its sweet sorghum hybrids, which can be grown as a lower-cost complement to sugarcane.

This season the company dispersed its field evaluations across a number of growing areas in south central Brazil in order to mitigate the impact of variations in weather conditions on the performance of its seed products. Sorghum also has a natural tolerance to hot and dry conditions.

"The timing of the rainfall has proved as important as the overall volume of water," said Richard Hamilton, Ceres President and CEO. He noted that generally favorable conditions during the beginning and end of the growing season have had a positive impact on plant growth. "Based on estimates from our agronomists, we have a high degree of confidence in our high biomass sorghum types at this point, and look forward to getting final yields of these products," he said. Ethanol yields for Ceres' sweet sorghum hybrids will not be known until harvests are completed and ethanol yields can be calculated.

In addition to its customer evaluations, Ceres has a number of new sorghum hybrids moving forward in its product development pipeline. "We are optimistic that even under adverse weather conditions we will be able to demonstrate ongoing performance improvements across our high biomass and sweet sorghum product pipelines," said Hamilton.

Ceres expects to collect performance data on its sorghum hybrids from more than 40 sites in south central Brazil. This data will be used to guide hybrid selections and planting decisions for the next season of mill evaluations, which begins in November. Ceres estimates that the high biomass sorghum and sweet sorghum market opportunities in Brazil are approximately one million hectares (2.4 million acres) each.

ABOUT CERES

Ceres, Inc. is an agricultural biotechnology company that markets seeds for energy crops used in the production of renewable transportation fuels, electricity and bio-based products. The company combines advanced plant breeding and biotechnology to develop products that can address the limitations of first-generation bioenergy feedstocks, increase biomass productivity, reduce crop inputs and improve cultivation on marginal land. Its development activities include sweet sorghum, high-biomass sorghum, switchgrass and miscanthus. Ceres markets its products under its Blade brand. The company also licenses its technology and biotech traits to other organizations.

CERES FORWARD-LOOKING STATEMENTS

This press release contains forward-looking statements. All statements, other than statements of historical facts, including statements regarding Ceres' efforts to develop and commercialize its products, anticipated yields and product performance, status of crop plantings, short-term and long-term business strategies, market and industry expectations, future operating metrics, and future results of operations and financial position, including anticipated cost savings from our plan to align expenditures, are forward-looking statements. You should not place undue reliance on these forward-looking statements because they involve known and unknown risks, uncertainties and other factors that are, in some cases, beyond Ceres' control. Factors that could materially affect actual results can be found in Ceres' filings with the U.S. Securities and Exchange Commission. Ceres undertakes no obligation to update publicly, except to the extent required by law, any forward-looking statements for any reason after the date the company issues this press release to conform these statements to actual results or to changes in the company's expectations.

SOURCE Ceres, Inc.


Quelle: PR Newswire  

http://www.ariva.de/news/...rd-Quarter-2014-Financial-Results-5089313 GrB  

Ceres Licenses DNA Browser Software to Bayer CropScience
14:05 08.07.14

PR Newswire

THOUSAND OAKS, Calif., July 8, 2014

THOUSAND OAKS, Calif., July 8, 2014 /PRNewswire/ -- Ceres, Inc. (NASDAQ: CERE), an agricultural biotechnology and seed company, today announced that the company has licensed its Persephone genome visualization application to Bayer CropScience. The multi-year software license and collaboration agreement provides a non-exclusive license to Bayer as well as professional services including support, customizations and maintenance. Bayer is the second multi-national life sciences company to license Persephone as its primary genome browser.

Originally developed for in-house use by Ceres, Persephone allows researchers to rapidly zoom in and out of massive amounts of genetic data, from a chromosome level to a single building block of DNA. On top of this data, users can layer and cross reference related information in much the same way geographic mapping services allow users to add weather information or business locations to a geographic map.

"We are proud to have Bayer select Persephone as its primary genome browser for its in-house R&D, and we look forward to working with Bayer for many years to come," said Richard Hamilton, President and CEO of Ceres. "The explosion of low cost full genome DNA sequencing, from plant science to biomedical research, is creating incredibly large data sets that are rich sources of information if mined effectively.  Persephone provides us with a significant near-term opportunity to leverage our expertise in bioinformatics and genetic analysis, while accelerating our own internal research and development work," Hamilton said.

Dr. Jakob de Vlieg, Head of the Computational Life Sciences group at Bayer CropScience said, "Our company will benefit from implementing this integrated solution, as this platform is allowing interactive querying and integrated visualization of various omics data. The Persephone genome browser impressed both our geneticists and bioinformaticians with its performance and user friendly interface. Persephone will allow them to make decisions on experimental approaches."

Tim Swaller, Ceres' Vice President of Genomics Technologies, noted that speed is taken for granted across most software markets, but the genetics market has struggled with massive datasets generated by DNA sequencing and genetic testing. For instance, a typical genome contains multiple terabytes of data. Plant genomes, which can be larger than the human genome, have been some of the most challenging.

To help solve the speed problem, and expand the way researchers can explore and mine genetic data, Persephone software engineers have developed a number of proprietary data-compression methods and other optimizations. "The speed itself changes the way researchers can use their data. It encourages more exploratory research and better utilization of genetic data," said Swaller. Ceres has used Persephone in its marker-assisted breeding and biotech trait pipelines to speed the development of elite parental breeding lines and improved sorghum hybrids for Brazil.

Swaller said that Persephone can be deployed across a number of life science technology platforms that utilize genetic data. Ceres currently offers Persephone as a client-server installation and is developing a Software as a Service (SaaS) model that is intended to provide individual researchers with an online tool to visualize and compare genetic information stored in public databases. The company has targeted the deployment of a cloud-based beta version of Persephone by the end of this year.

"We believe there is a large number of individual researchers currently that could benefit from the Persephone interface," Swaller said. He noted that Ceres is also exploring opportunities for the software outside of the plant sciences.

About Persephone

Persephone is a genome visualization application marketed by Ceres, Inc. The software allows researchers to explore DNA databases in much the same way online mapping programs allow users to explore geographic regions and places. Persephone has been designed to display diverse data such as genetic maps, genomic sequences, gene models, synteny, QTLs, SNPs, RNA-Seq, and gene expression, among others. The software features an ultra-fast graphics-rendering engine that can load and visualize 30 million SNPs in 30 seconds in client-server installations. Persephone is a trademark of Ceres, Inc.

About Ceres

Ceres, Inc. is an agricultural biotechnology company that markets seeds for energy crops used in the production of renewable transportation fuels, electricity and bio-based products. The company also licenses its genetics technology, software and biotech traits to other organizations.

Ceres Forward-Looking Statements

This press release may contain forward-looking statements. All statements, other than statements of historical facts, including statements regarding Ceres' efforts to develop and commercialize its products, anticipated yields and product performance, status of crop plantings, short-term and long-term business strategies, market and industry expectations, future operating metrics, and future results of operations and financial position, including anticipated cost savings from our plan to align expenditures, are forward-looking statements. You should not place undue reliance on these forward-looking statements because they involve known and unknown risks, uncertainties and other factors that are, in some cases, beyond Ceres' control. Factors that could materially affect actual results can be found in Ceres' filings with the U.S. Securities and Exchange Commission. Ceres undertakes no obligation to update publicly, except to the extent required by law, any forward-looking statements for any reason after the date the company issues this press release to conform these statements to actual results or to changes in the company's expectations.

SOURCE Ceres, Inc.


Quelle: PR Newswire  

http://www.ariva.de/news/...rd-Quarter-2014-Financial-Results-5097159 GrB  

and Sugarcane Under Brazil's Agricultural Innovation Program
13:20 28.07.14

PR Newswire

THOUSAND OAKS, Calif., July 28, 2014

THOUSAND OAKS, Calif., July 28, 2014 /PRNewswire/ -- Ceres, Inc. (Nasdaq: CERE), an agricultural biotechnology and seed company, today announced that the company will enhance its product development programs in Brazil and expand its development activities in biotech traits for sorghum and sugarcane over the next four years. The programs will now be funded in part under the Brazilian government's PAISS Agricola initiative, which promotes agricultural innovations in sugarcane as well as other energy crops.

Under the PAISS program, Ceres is eligible for a multi-year credit facility of up to 75.4 million reais, or approximately US$34 million, at a government-subsidized, preferential interest rate. Receipt of the loan will be subject to customary diligence, documentation and closing conditions, and will require guarantees to be provided by or obtained by Ceres. The company was also awarded 10 million reais, or approximately US$4.5 million, in the form of non-repayable grants to be drawn over four years. Ceres expects to complete the application and grant award process by the end of calendar year 2014.

"We were pleased to be selected to participate in this prestigious agricultural innovation program and to receive this clear endorsement for utilizing sorghum and biotechnology in sugarcane to increase production of ethanol and biopower," said Paul Kuc, Chief Financial Officer of Ceres. "The funding will allow us to accelerate our product development programs in Brazil and will extend our capital resources as we continue to develop the commercial markets for our technology and products."

Andre Franco, General Manager of Ceres Sementes do Brasil, indicated that embracing innovations has been the cornerstone of Brazil's success in agricultural commodities. In this case, Brazil can not only adopt new technologies, but also take the lead in developing them domestically.

"Increasing yields and providing greater yield stability from season to season represents a key opportunity for Brazil to strengthen its global position in sugar and ethanol production," said Franco. "We look forward to working with our mill customers and other industry leaders to evaluate and bring new products to market that can increase efficiencies and lower the cost of production."

The PAISS project is jointly managed by Brazil's national development bank, BNDES, and by the government's research financing agency, FINEP. The competitive application process included over 60 proposals. Ceres was one of only five organizations to be selected for both a loan and a grant.

ABOUT CERES

Ceres, Inc. is an agricultural biotechnology company that markets seeds for energy crops used in the production of renewable transportation fuels, electricity and bio-based products. Ceres markets its products under its Blade brand. The company also licenses its technology and biotech traits to other organizations.

CERES FORWARD-LOOKING STATEMENTS

This press release contains forward-looking statements. All statements, other than statements of historical facts, including statements regarding Ceres' efforts to develop and commercialize its products, anticipated yields and product performance, status of crop plantings, short-term and long-term business strategies, market and industry expectations, future operating metrics, and future results of operations and financial position, including anticipated cost savings from our plan to align expenditures, are forward-looking statements. You should not place undue reliance on these forward-looking statements because they involve known and unknown risks, uncertainties and other factors that are, in some cases, beyond Ceres' control. Factors that could materially affect actual results can be found in Ceres' filings with the U.S. Securities and Exchange Commission. Ceres undertakes no obligation to update publicly, except to the extent required by law, any forward-looking statements for any reason after the date the company issues this press release to conform these statements to actual results or to changes in the company's expectations.

SOURCE Ceres, Inc.


Quelle: PR Newswire  

Ceres Announces Passing of Chairman of the Board
22:50 05.08.14

PR Newswire

THOUSAND OAKS, Calif., Aug. 5, 2014

THOUSAND OAKS, Calif., Aug. 5, 2014 /PRNewswire/ -- Ceres, Inc. (Nasdaq: CERE), an agricultural biotechnology and seed company, announced today the death of Dr. Walter De Logi, Chairman of the Board and a co-founder of Ceres. Dr. De Logi died unexpectedly at the age of 63.

"We are deeply saddened by the loss of our dear friend and colleague, and our thoughts are with his family during this difficult time," said Richard Hamilton, President and Chief Executive Officer of Ceres. "Walter was a remarkable individual – a mentor to many and a visionary who believed deeply in the positive impact that plant science could have on the world. He leaves us with a tremendous legacy and will be deeply missed."

Dr. De Logi served on Ceres' board of directors since the company's inception and as Chairman of the Board since 2002. He was Ceres' President and Chief Executive Officer from 1996 until 2002. Prior to co-founding Ceres, Dr. De Logi was the Chief Executive Officer of Plant Genetic Systems, an eminent first generation plant biotechnology company that was sold to Hoechst Schering AgrEvo, now part of Bayer, in 1996. He held an MBA from Harvard University and a PhD from the California Institute of Technology.

About Ceres

Ceres, Inc. is an agricultural biotechnology company that markets seeds for energy crops used in the production of renewable transportation fuels, electricity and bio-based products. The company combines advanced plant breeding and biotechnology to develop products that can address the limitations of first-generation bioenergy feedstocks, increase biomass productivity, reduce crop inputs and improve cultivation on marginal land. Its development activities include sweet sorghum, high biomass sorghum, switchgrass and miscanthus. Ceres markets its products under its Blade brand. The company also licenses its technology and biotech traits to other organizations. Persephone is a trademark of Ceres, Inc.

Ceres Forward-Looking Statements

This press release may contain forward-looking statements. All statements, other than statements of historical facts, including statements regarding Ceres' efforts to develop and commercialize its products, anticipated yields and product performance, status of crop plantings, short-term and long-term business strategies, market and industry expectations, future operating metrics, and future results of operations and financial position, including anticipated cost savings from the company's plan to align expenditures, are forward-looking statements. You should not place undue reliance on these forward-looking statements because they involve known and unknown risks, uncertainties and other factors that are, in some cases, beyond Ceres' control. Factors that could materially affect actual results can be found in Ceres' filings with the U.S. Securities and Exchange Commission. Ceres undertakes no obligation to update publicly, except to the extent required by law, any forward-looking statements for any reason after the date the company issues this press release to conform these statements to actual results or to changes in the company's expectations.

SOURCE Ceres, Inc.


Quelle: PR Newswire  

Bucheinsicht
http://www.ariva.de/ceres_inc_com_usd0.01-aktie/...sales?boerse_id=40 GrB  

Nasdaq 0,5822  $  Frankfurt 0,454  €   Stuttgart 0,443  €

buran und MfG und danke und weitermachen und sowieso und überhaupt ..::hopshops  

buran: nur ein börsenboard geführt von www.bundesbank.de 21:18 #1
achte er einfach auf die links
Mit freundlichen Grüssen Mario Meierhof 39517 Lüderitz Gartenstrasse 6
mariomeierhof@web.de
Tel.:039361/96548 Atelier Meierhof 039361/51273 Kuhle
gez MARIO alias buran http://www.ariva.de/…/nur-ein-boersenboard-gefuehrt-von-www…

Deutsche Bundesbank - Startseite
Die Deutsche Bundesbank ist die Zentralbank der Bundesrepublik Deutschland. Zentrales Geschäftsfeld ist die Geldpolitik des Eurosystems.
BUNDESBANK.DE
https://www.facebook.com/mario.meierhof  

lange eine Ewigkeit 228.10.14 20:01 #1
Mario Meierhof
29. September um 21:38 ·
buran: nur ein börsenboard geführt von www.bundesbank.de 21:18 #1
achte er einfach auf die links
Mit freundlichen Grüssen Mario Meierhof 39517 Lüderitz Gartenstrasse 6
mariomeierhof@web.de
Tel.:039361/96548 Atelier Meierhof 039361/51273 Kuhle
gez MARIO alias buran http://www.ariva.de/…/nur-ein-boersenboard-gefuehrt-von-www…

Deutsche Bundesbank - Startseite
Die Deutsche Bundesbank ist die Zentralbank der Bundesrepublik Deutschland. Zentrales Geschäftsfeld ist die Geldpolitik des Eurosystems.
BUNDESBANK.DE
https://www.facebook.com/mario.meierhof
http://www.ariva.de/forum/...rziehungsheim-lange-eine-Ewigkeit-510117  

Mitglieder des "Clearing House" werden als "Clearing Member" bezeichnet. Das Mitglied muß gleichzeitig einen Börsensitz haben, wobei umgekehrt Nichtmitglieder auch im Clearing House tätig sein können. Diese zahlen allerdings eine höhere Kommission. http://www.ariva.de/extras/lexikon.m?begriff=Clearing_Member
 

Datum Erster Hoch Tief Schluss     Stücke Volumen
  13.02.15     0,234     0,234§0,19 0,196 € 2.900 679

GrB  

Datum Erster Hoch Tief Schluss     Stücke Volumen
  13.02.15      0,26      0,26§0,23 0,2402 $ 369.493 91 T

GrB  

..yöah  

-88,45%

..yöah

GRINS ...

 

 

Ceres Awarded Patent for Innovation in Soybean
Date : 05/27/2015 @ 7:45AM
Source : PR Newswire (US)
Stock : Ceres, Inc. (MM) (CERE)
Quote : 3.77  2.09 (124.40%) @ 12:00PM
                    §
Ceres Awarded Patent for Innovation in Soybean
Print
Ceres, Inc. (MM) (NASDAQ:CERE)
Intraday Stock Chart

Today : Wednesday 27 May 2015
Click Here for more Ceres, Inc. (MM) Charts.

THOUSAND OAKS, Calif., May 27, 2015 /PRNewswire/ -- Ceres, Inc. (Nasdaq: CERE), an agricultural biotechnology company, has been awarded a U.S. patent for a genetic sequence derived from soybean, covering uses of the gene in areas such as research, product development and plant transformation. The company believes that its gene is useful in regulating key biosynthetic processes that are the target of a class of commercial herbicides. Ceres plans to offer other seed companies a commercial license to the innovation, including an opportunity for exclusivity in certain crops.

Richard Hamilton, President and CEO of Ceres, said that the company is currently evaluating the potential market for this gene among soybean seed companies and the use of its patented invention in the development and production of improved soybean varieties.

Ceres' biotechnology platform, which has proven to increase crop productivity, raise quality, reduce crop inputs and improve cultivation on marginal land, has broad application across multiple markets and crops.

Hamilton noted that growers are facing increasing demand for food, feed, fiber and fuel as a result of rising global population and an expanding middle class in certain regions. "The need for technology improvements has become more pressing due to stresses from climate variability and competition for water resources," said Hamilton. "Agricultural biotechnology has and will continue to represent a significant source of innovation for increasing crop yields through improving performance of seeds."

The new patent for this invention was issued by the U.S. Patent and Trademark Office as U.S. Patent No. 9,024,004 and is titled, Sequence-Determined DNA Fragments Encoding Acetohydroxyacid Synthase Proteins. Ceres owns or maintains exclusive licensed rights to approximately 85 issued patents and numerous pending patent applications in the United States and in various foreign jurisdictions. A patent is an intellectual property right granted by a government to an inventor to exclude others from making, using, offering for sale, or selling the invention for a limited time in exchange for public disclosure of the invention when the patent is granted.

Soybean is one of the most valuable and widely planted row crops in the world. From 2003 to 2013, the number of acres planted increased 2.4% annually, to 275 million acres today, according to the Food and Agriculture Organization of the United Nations. Soybeans are used for oil, feed for livestock and aquaculture, as a biofuel feedstock and as a protein for the human diet.

About Ceres
Ceres, Inc. is an agricultural biotechnology company that develops and markets seeds to produce crops for forage, biofuels and other markets that utilize plant biomass. The company's advanced plant breeding and biotechnology technology platforms, which can increase crop productivity, improve quality, reduce crop inputs and improve cultivation on marginal land, have broad application across multiple crops, including food, feed, fiber and fuel crops. Ceres markets its seed products under its Blade brand. The company also licenses its biotech traits and technology, including its Persephone genome visualization software, to other life science companies and organizations.

Ceres Forward-Looking Statements
This press release may contain forward-looking statements. All statements, other than statements of historical facts, including statements regarding Ceres' efforts to develop and commercialize its products and technologies, anticipated yields and product performance, status of crop plantings, short-term and long-term business strategies, market and industry expectations, future operating metrics, and future results of operations and financial position, including anticipated cost savings from the company's plan to align expenditures and projected cash expenditures, are forward-looking statements. You should not place undue reliance on these forward-looking statements because they involve known and unknown risks, uncertainties and other factors that are, in some cases, beyond Ceres' control. Factors that could materially affect actual results can be found in Ceres' filings with the U.S. Securities and Exchange Commission. Ceres undertakes no obligation to update publicly, except to the extent required by law, any forward-looking statements for any reason after the date the company issues this press release to conform these statements to actual results or to changes in the company's expectations.

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/...-in-soybean-300089077.html

SOURCE Ceres, Inc.

Copyright 2015 PR Newswire  

-84,97%
..yöah
GRINS ...

 

Grins immer noch $$$  

http://www.ceres.net/Index.html  

Ceres skyrockets after winning U.S. patent for soybean innovation
May 27 2015, 14:11 ET | By: Carl Surran, SA News Editor [Contact this editor with comments or a news tip]

   Ceres (CERE +101.8%) shares more than double after the agricultural biotech company says it received a U.S. patent for a genetic sequence derived from soybeans affecting plant development and transformation such as boosting yields or adapting soybeans for biofuel production.
   CERE believes the gene has applications in regulating major biosynthetic practices related to commercial herbicides, and aims to market a commercial license for its innovation to other seed businesses, which also includes an option for exclusivity in specific crops.
   CERE says soybean is one of the most popular and profitable cash crops in the world, as the number of acres farmers planted increased 2.4%/year during 2003-13 to 275M acres worldwide.

765 people get CERE breaking news and analysis by email alert.

http://seekingalpha.com/news/...ing-u-s-patent-for-soybean-innovation  

http://ih.advfn.com/stock-market/NASDAQ/CERE/stock-price